[1]
L. Ravikumar, R. S. Kiwalkar, R. H. S, B. Lokesh, and D. Dabhade, “Dapagliflozin and Sitagliptin Combination Therapy: An Overview of Clinical Utility in Type 2 Diabetes Mellitus with Multiple Cardiovascular Risk Factors”, ccm, vol. 7, no. 2, pp. 141–144, Apr. 2023.